Aberrant forkhead box O1 function is associated with impaired hepatic metabolism

Endocrinology

Volumn 147, Issue 12, 2006, Pages 5641-5652

  Qu, Shen ^a   Altomonte, Jennifer ^b   Perdomo, German ^a   He, Jing ^a   Fan, Yong ^a   Kamagate, Adama ^a   Meseck, Marcia ^b   Dong, H Henry ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIABETES MELLITUS; FATTY LIVER; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; LIVER METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELLS, CULTURED; DIET, ATHEROGENIC; FASTING; FATTY ACIDS; FORKHEAD TRANSCRIPTION FACTORS; GLUCOSE; HUMANS; LIVER; LIVER GLYCOGEN; MICE; MICE, INBRED C57BL; MICE, OBESE; MICE, TRANSGENIC; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION;

EID: 33751507689     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0541     Document Type: Article

References (39)

1. Pilkis SJ, Granner DK 1992 Molecular physiology of the regulation of hepatic gluconeogenesis and glycogenolysis. Annu Rev Physiol 54:885-909
2. Giaccari A, Morviducci L, Pastore L, Zorretta D, Sbraccia P, Maroccia E, Buongiorno A, Tamburrano G 1998 Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglyceamia. Diabetologia 41:307-314
3. Magnuson MA, Rothman DL, Katz LD, Shulman RG, Shulman GI 1992 Increased rate of gluconeogenesis in type II diabetes mellitus: a 13C nuclear magnetic resonance study. J Clin Invest 90:1322-1327
4. Boden G, Chen X, Stein TP 2001 Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-E30
5. Kaestner KH, Knochel W, Martinez DE 2000 Unified nomenclature for the winged helix/forkhead transcription factors. Gene Dev 14:142-146
6. Nakae J, Park B-C, Accili D 1999 Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J Biol Chem 274:15982-15985
7. Nakae J, Barr V, Accili D 2000 Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 19:989-996
8. Durham SK, Suwanichkul A, Scheimann AO, Yee D, Jackson JG, Barr FG, Powell DR 1999 FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology 140:3140-3146
9. Kops GJ, Burgering BM 1999 Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med 77:656-665
10. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, Momoi M, Ozawa K, Komatsu N 2000 A member of forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phophatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Hematopoisis 96:941-949
11. Lin K, Dorman JB, Rodan A, Kenyon C 1997 Daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278:1319
12. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426
13. Nakae J, Biggs WH, Kitamura T, Cavenee W, Wright CVE, Arden KC, Accili D 2002 Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245-253
14. Altomonte J, Richter A, Harbaran S, Suriawinata j, Nakae J, Thung SN, Meseck M, Accili D, Dong H 2003 Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol 285:E718-E728
15. Nakae J, Kitamura T, Kitamura Y, Biggs 3rd WH, Arden KC, Accili D 2003 The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell 4:119-129
16. Samuel VT, Choi CS, Phillips TG, Romanelli AJ, Geisler JG, Bhanot S, McKay R, Monia B, Shutter JR, Lindberg RA, Shulman GI, Veniant MM 2006 Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55:2042-2050
17. Nakae J, Kitamura T, Silver DL, Accili D 2001 The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359-1367
18. Dong H, Altomonte J, Morral N, Meseck M, Thung SN, Woo SLC 2002 Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes 51:130-138
19. Rossetti L, Chen W, Hu M, Hawkins M, Barzilai N, Efrat S 1997 Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am J Physiol 273:E743-E750
20. Altomonte J, Harbaran S, Richter A, Dong H 2003 Fat-depot specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 52:958-963
21. Dong H, Morral N, McEvoy R, Meseck M, Thung SN, Woo SLC 2001 Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Res Clin Pract 52:153-163
22. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G 1995 The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 2:107-115
23. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Liepvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferre P, Foufelle F 1999ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19:3760-3768
24. Foretz M, Guichard C, Ferre P, Foufelle F 1999 Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96:12737-12742
25. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM 2005 Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell 120:261-273
26. Altomonte J, Cong L, Harbaran S, Richter A, Xu J, Meseck M, Dong HH 2004 Foxo1 mediates insulin action on ApoC-III and triglyceride metabolism. J Clin Invest 114:1493-1503
27. Imae M, Fu Z, Yoshida A, Noguchi T, Kato H 2003 Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF-16. J Mol Endocrinol 30:253-262
28. Valera A, Pujol A, Pelegrin M, Bosch F 1994 Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:9151-9154
29. Fisher SJ, Kahn CR 2003 Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest 111:463-468
30. Zhao X, Gan L, Pan H, Kan D, Majeski M, Adam SA, Unterman TG 2004 Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 378:839-849
31. Tsai WC, Bhattacharyya N, Han LY, Hanover JA, Rechler MM 2003 Insulin inhibition of transcription stimulated by the forkhead protein Foxo1 is not solely due to nuclear exclusion. Endocrinology 144:5615-5622
32. Zhang X, Gan L, Pan H, Guo S, He X, Olson ST, Mesecar A, Adam S, Unterman TG 2002 Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding. J Biol Chem 277:45276-45284
33. Altomonte J, Anthony K, Baliga S, Xu J, Dong H 2004 Foxo1 plays a role in mediating the effect of fibrates on diabetic dyslipidemia. Diabetes 53(Suppl 2):A227
34. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839-1847
35. Zhang J, Ou J, Bashmakov Y, Horton JD, Brown MS, Goldstein JL 2001 Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes. Proc Natl Acad Sci USA 98:3756-3761
36. Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, Yamamoto T, Nakagawa Y, Takahashi A, Suzuki H, Sone H, Toyoshima H, Fukamizu A, Yamada N 2004 SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat Cell Biol 6:351-357
37. Qu S, Su D, Altomonte J, Kamagate A, He J, Perdomo G, Tse T, Jiang Y, Dong HH PPAR-α mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab, in press
38. Matsumoto M, Han S, Kitamura T, Accili D 2006 Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest, 116:2464-2472
39. Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, Klotsas A, Matika R, Xiao X, Franks R, Heidenreich KA, Sajan MP, Farese RV, Stolz DB, Tso P, Koo SH, Montminy M, Unterman TG 2006 FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281:10105-10117